BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Argus Health
Julphar
McKesson
Mallinckrodt
Deloitte
Cipla
Chinese Patent Office
Fuji
Medtronic

Generated: January 20, 2018

DrugPatentWatch Database Preview

PEPCID Drug Profile

« Back to Dashboard

Which patents cover Pepcid, and when can generic versions of Pepcid launch?

Pepcid is a drug marketed by Salix Pharms, Merck, Valeant Pharms North, J And J Consumer Inc, and Merck Sharp Dohme. and is included in nine NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in PEPCID is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and seventy-two drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.

US Patents and Regulatory Information for PEPCID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Salix Pharms PEPCID famotidine FOR SUSPENSION;ORAL 019527-001 Feb 2, 1987 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 OTC Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck PEPCID PRESERVATIVE FREE famotidine INJECTABLE;INJECTION 019510-004 Nov 4, 1986 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-002 Sep 23, 2003 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck PEPCID RPD famotidine TABLET, ORALLY DISINTEGRATING;ORAL 020752-001 May 28, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck PEPCID famotidine INJECTABLE;INJECTION 019510-001 Nov 4, 1986 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-001 Oct 15, 1986 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-002 Dec 17, 2007 OTC Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-001 Sep 24, 1998 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PEPCID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Salix Pharms PEPCID famotidine FOR SUSPENSION;ORAL 019527-001 Feb 2, 1987 ➤ Subscribe ➤ Subscribe
Merck PEPCID famotidine INJECTABLE;INJECTION 019510-001 Nov 4, 1986 ➤ Subscribe ➤ Subscribe
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 ➤ Subscribe ➤ Subscribe
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-001 Oct 15, 1986 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for PEPCID
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Chewable Tablets 800 mg/ 10 mg/ 165 mg (OTC) ➤ Subscribe 11/1/2004

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
Colorcon
Covington
Farmers Insurance
Argus Health
Baxter
Medtronic
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot